These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

70 related articles for article (PubMed ID: 21110023)

  • 1. Induction of fetal hemoglobin and ABCB1 gene expression in 9-β-D-arabinofuranosylguanine-resistant MOLT-4 cells.
    Fyrberg A; Peterson C; Kågedal B; Lotfi K
    Cancer Chemother Pharmacol; 2011 Sep; 68(3):583-91. PubMed ID: 21110023
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A potential role of fetal hemoglobin in the development of multidrug resistance.
    Fyrberg A; Skoglund K; Wolk M; Lotfi K
    Biochem Biophys Res Commun; 2012 Oct; 427(3):456-60. PubMed ID: 22910410
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dual mechanisms of 9-beta-D-arabinofuranosylguanine resistance in CEM T-lymphoblast leukemia cells.
    Curbo S; Zhu C; Johansson M; Balzarini J; Karlsson A
    Biochem Biophys Res Commun; 2001 Jul; 285(1):40-5. PubMed ID: 11437369
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Induction of multidrug resistance in MOLT-4 cells by anticancer agents is closely related to increased expression of functional P-glycoprotein and MDR1 mRNA.
    Liu ZL; Onda K; Tanaka S; Toma T; Hirano T; Oka K
    Cancer Chemother Pharmacol; 2002 May; 49(5):391-7. PubMed ID: 11976833
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differential metabolism of 9-beta-D-arabinofuranosylguanine in human leukemic cells.
    Shewach DS; Mitchell BS
    Cancer Res; 1989 Dec; 49(23):6498-502. PubMed ID: 2819707
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Development and characterization of P-glycoprotein 1 (Pgp1, ABCB1)-mediated doxorubicin-resistant PLHC-1 hepatoma fish cell line.
    Zaja R; Caminada D; Loncar J; Fent K; Smital T
    Toxicol Appl Pharmacol; 2008 Mar; 227(2):207-18. PubMed ID: 18076962
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinically relevant deoxycytidine levels are high enough to profoundly alter 9-beta-D-arabinofuranosylguanine cytotoxicity for human T-cell acute leukemia cells in vitro.
    Cohen JD; Strock DJ; Teik JE; LaGuardia EA; Katz TB
    Pediatr Hematol Oncol; 1999; 16(3):239-44. PubMed ID: 10326222
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Low level of mitochondrial deoxyguanosine kinase is the dominant factor in acquired resistance to 9-beta-D-arabinofuranosylguanine cytotoxicity.
    Lotfi K; Månsson E; Peterson C; Eriksson S; Albertioni F
    Biochem Biophys Res Commun; 2002 May; 293(5):1489-96. PubMed ID: 12054684
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The proteasome inhibitor bortezomib reverses P-glycoprotein-mediated leukemia multi-drug resistance through the NF-kappaB pathway.
    Wang H; Wang X; Li Y; Liao A; Fu B; Pan H; Liu Z; Yang W
    Pharmazie; 2012 Feb; 67(2):187-92. PubMed ID: 22512091
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cediranib (recentin, AZD2171) reverses ABCB1- and ABCC1-mediated multidrug resistance by inhibition of their transport function.
    Tao LY; Liang YJ; Wang F; Chen LM; Yan YY; Dai CL; Fu LW
    Cancer Chemother Pharmacol; 2009 Oct; 64(5):961-9. PubMed ID: 19255759
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of 9-beta-D-arabinofuranosylguanine on mitochondria in CEM T-lymphoblast leukemia cells.
    Curbo S; Zhivotovsky B; Johansson M; Karlsson A
    Biochem Biophys Res Commun; 2003 Aug; 307(4):942-7. PubMed ID: 12878202
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy and toxicity of 9-beta-D-arabinofuranosylguanine (araG) as an agent to purge malignant T cells from murine bone marrow: application to an in vivo T-leukemia model.
    Gravatt LC; Chaffee S; Hebert ME; Halperin EC; Friedman HS; Kurtzberg J
    Leukemia; 1993 Aug; 7(8):1261-7. PubMed ID: 8350627
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Decreased expression of nucleophosmin/B23 increases drug sensitivity of adriamycin-resistant Molt-4 leukemia cells through mdr-1 regulation and Akt/mTOR signaling.
    Wang L; Chen B; Lin M; Cao Y; Chen Y; Chen X; Liu T; Hu J
    Immunobiology; 2015 Mar; 220(3):331-40. PubMed ID: 25457413
    [TBL] [Abstract][Full Text] [Related]  

  • 14. L-type calcium channel blockers reverse docetaxel and vincristine-induced multidrug resistance independent of ABCB1 expression in human lung cancer cell lines.
    Chiu LY; Ko JL; Lee YJ; Yang TY; Tee YT; Sheu GT
    Toxicol Lett; 2010 Feb; 192(3):408-18. PubMed ID: 19944135
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Triapine-mediated ABCB1 induction via PKC induces widespread therapy unresponsiveness but is not underlying acquired triapine resistance.
    Miklos W; Pelivan K; Kowol CR; Pirker C; Dornetshuber-Fleiss R; Spitzwieser M; Englinger B; van Schoonhoven S; Cichna-Markl M; Koellensperger G; Keppler BK; Berger W; Heffeter P
    Cancer Lett; 2015 May; 361(1):112-20. PubMed ID: 25749419
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The temporal relationship between ABCB1 promoter hypomethylation, ABCB1 expression and acquisition of drug resistance.
    Reed K; Hembruff SL; Sprowl JA; Parissenti AM
    Pharmacogenomics J; 2010 Dec; 10(6):489-504. PubMed ID: 20125118
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reversal of mdr1-mediated multidrug resistance in human leukemia cells by a new spin-labeled derivative of podophyllotoxin.
    Qi SN; Song LJ; Chen Y; Jing YX
    Pharmazie; 2010 Feb; 65(2):117-21. PubMed ID: 20225656
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression of the multidrug resistance P-glycoprotein, (ABCB1 glycoprotein) in the human placenta decreases with advancing gestation.
    Sun M; Kingdom J; Baczyk D; Lye SJ; Matthews SG; Gibb W
    Placenta; 2006; 27(6-7):602-9. PubMed ID: 16143395
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reversal of MDR1 gene-dependent multidrug resistance in HL60/HT9 cells using short hairpin RNA expression vectors.
    Shao SL; Zhang WW; Li XY; Zhang ZZ; Yun DZ; Fu B; Zuo MX
    Cancer Biother Radiopharm; 2010 Apr; 25(2):171-7. PubMed ID: 20423230
    [TBL] [Abstract][Full Text] [Related]  

  • 20. ABCB1/MDR1 contributes to the anticancer drug-resistant phenotype of IPH-926 human lobular breast cancer cells.
    Krech T; Scheuerer E; Geffers R; Kreipe H; Lehmann U; Christgen M
    Cancer Lett; 2012 Feb; 315(2):153-60. PubMed ID: 22118813
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.